| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/2006 | US20060047007 Method for treating urinary disorders |
| 03/02/2006 | US20060047006 Microbiocides; for disinfecting and/or preserving medical devices, contact lenses |
| 03/02/2006 | US20060047005 Compositions containing N,N,N',N'-tetrakis(hydroxyalkyl)diamine-or N,N,N',N'-tetrakis(hydroxyalkoxy)diamine-based buffers |
| 03/02/2006 | US20060047004 HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy |
| 03/02/2006 | US20060047003 Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis |
| 03/02/2006 | US20060047002 Acetalizing a 5-aminoshikimic ester, reductive ketal ring opening, replacing the 4-hydroxy group with an amine group and the 5-free amino group with a secondary or tertiary amine group, acylating the 4-amino group, and cleaving the substituents on the 5-amino group to reform the free amine group |
| 03/02/2006 | US20060047001 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 03/02/2006 | US20060047000 Detoxification; hydrolases or esterases; short half-life; antidiabetic agents; side effect reduction |
| 03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
| 03/02/2006 | US20060046998 Method of treatment of gastroesophageal reflux disease and laryngopharyngeal reflux disease |
| 03/02/2006 | US20060046997 6-Alkenyl -, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 03/02/2006 | US20060046996 Method for treating hyperlipidemia |
| 03/02/2006 | US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen |
| 03/02/2006 | US20060046994 Process for preparing 3-oxo-4-aza-5-alpha-androstane-17-carboxylic acid |
| 03/02/2006 | US20060046993 Crystalline polymorphic form of irinotecan hydrochloride |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060046991 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 03/02/2006 | US20060046990 New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 03/02/2006 | US20060046989 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 03/02/2006 | US20060046987 Substituted quinazoline derivatives and their use as inhibitors |
| 03/02/2006 | US20060046986 e.g. 4-[2-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-1-methyl-1H-indole-7-carbonyl]-piperazine-1-carboxylic acid ethyl ester; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 03/02/2006 | US20060046985 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors |
| 03/02/2006 | US20060046984 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome |
| 03/02/2006 | US20060046983 Inhibitors of HCV replication |
| 03/02/2006 | US20060046982 Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
| 03/02/2006 | US20060046981 Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof |
| 03/02/2006 | US20060046980 Novel phosphorus-containing thyromimetics |
| 03/02/2006 | US20060046979 Organic compounds |
| 03/02/2006 | US20060046978 Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE) |
| 03/02/2006 | US20060046977 Furanopyridine derivatives and methods of use |
| 03/02/2006 | US20060046976 Method for increasing the bone mineral density and bone micro-architecture or connectivity of a mammal using N-acylated glucosamines |
| 03/02/2006 | US20060046975 Heat sterililzing a compartment containing a solution of one or more acetylated or deacetylated amino sugars including N-acetylglucosamine; sterilized solution contains low levels of cytotoxic degradation products and has a pH of 2.5-3.5 due to the acetic acid formed by thermolysis |
| 03/02/2006 | US20060046974 N-acyl modified polysaccharides and pharmaceutical compositions comprising same |
| 03/02/2006 | US20060046973 Compositions containing 5-amino-2-hydroxybenzoic acid and a reducing sugar |
| 03/02/2006 | US20060046972 Cytotoxic nucleoside analog compound 003 for treating cancer |
| 03/02/2006 | US20060046971 Treatment of transformed or infected biological cells |
| 03/02/2006 | US20060046970 Topical otic compositions and methods of topical treatment of prevention of otic infections |
| 03/02/2006 | US20060046969 Antibacterial compositions for drug administration |
| 03/02/2006 | US20060046968 Estrogen receptor modulators; each ligand potentially places the receptor in a unique and unpredictable conformation that is likely to have distinct biological activities and implications for gender related drug efficacy |
| 03/02/2006 | US20060046967 Prodrugs containing novel bio-cleavable linkers |
| 03/02/2006 | US20060046966 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/02/2006 | US20060046964 Pharmaceutical formulations and methods |
| 03/02/2006 | US20060046962 Absorption enhancers for drug administration |
| 03/02/2006 | US20060046958 Side effect reduction |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060045926 Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin |
| 03/02/2006 | US20060045913 A bilayer tablet for the treating of nervous system disorders associated with serotonin deficiencies having a rapid-release layer of 5-hydroxytryptophan and a slow-release layer of tryptophan or 5-hydroxytryptophan; physiological conditions; side effect reduction |
| 03/02/2006 | US20060045912 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| 03/02/2006 | US20060045911 Stable pharmaceutical formulations |
| 03/02/2006 | US20060045910 Preserved fusogenic vesicles |
| 03/02/2006 | US20060045906 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 03/02/2006 | US20060045905 Composition for repressing transformation growth factor beta |
| 03/02/2006 | US20060045900 Embolization |
| 03/02/2006 | US20060045886 HIV immunostimulatory compositions |
| 03/02/2006 | US20060045885 Method of eliciting an immune response against HIV |
| 03/02/2006 | US20060045874 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 03/02/2006 | US20060045873 Induction of methylation of CpG sequences by dsRNAS in mammalian cells |
| 03/02/2006 | US20060045869 Absorption enhancers for drug administration |
| 03/02/2006 | US20060045868 Absorption enhancers for drug administration |
| 03/02/2006 | US20060045866 Novel high purity and high molecular weight mPEG alcohol compositions |
| 03/02/2006 | US20060045865 Controlled regional oral delivery |
| 03/02/2006 | US20060045863 Self-polishing antifouling paint |
| 03/02/2006 | US20060045858 Composition and method for reducing harmful effects of ultraviolet radiation impinging on the skin |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | US20060045850 Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids |
| 03/02/2006 | US20060045794 Heat sterililzing a compartment containing a solution of one or more acetylated or deacetylated amino sugars including N-acetylglucosamine; sterilized solution contains low levels of cytotoxic degradation products and has a pH of 2.5-3.5 due to the acetic acid formed by thermolysis |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | DE19935763B4 Zusammensetzung eines Redoxsystems zur Stabilisierung von Retinoiden in Präparaten zur äußerlichen Anwendung Composition of a redox system for stabilization of retinoids in preparations for topical use |
| 03/02/2006 | DE19916896B4 Teilchen mit kleiner Dimension, die eine Wand aus einem Gemisch von vernetzten Proteinen und Polysacchariden aufweisen, die an der Oberfläche mit Metallionen chelatbildende Hydroxamgruppen enthalten, Verfahren zu ihrer Herstellung und ihre verschiedenen Verwendungen insbesondere in der kosmetischen, pharmazeutischen und Nahrungsmittelindustrie Particles having smaller dimensions, which have a wall composed of a mixture of cross-linked proteins, and polysaccharides containing on the surface with metal ions chelating hydroxamic groups, process for their preparation and to their different uses, particularly in the cosmetic, pharmaceutical and food industry |
| 03/02/2006 | DE102005035472A1 Chemische Dialysatformulierungen auf Citratbasis Dry on citrate dialysate |
| 03/02/2006 | DE102004056838A1 Composition containing a sympathomimetic, useful for treating pruritus ani and hemorrhoids, optionally also containing a coumarin and local anesthetic |
| 03/02/2006 | DE102004041253A1 Neues Verfahren zur Herstellung von Tiotropiumsalzen New method for the preparation of tiotropium |
| 03/02/2006 | DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 03/02/2006 | DE102004040736A1 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 03/02/2006 | DE102004040168A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis) |
| 03/02/2006 | DE102004039789A1 Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039533A1 Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexylmethoxy-acetic acid derivatives having substituents, processes for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039532A1 Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexyl-methyloxy-substituted acetic acid derivatives, process for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039507A1 Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-Aminoalkoxi-xanthines, processes for their preparation and their use as medicaments |
| 03/02/2006 | DE102004039196A1 Neue Formulierung für L-Tryptophan New formulation of L-tryptophan |
| 03/02/2006 | DE102004032567A1 Substituierte 1-Propiolyl-piperazine Substituted 1-piperazine-propiolyl |
| 03/02/2006 | CA2803995A1 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 03/02/2006 | CA2689274A1 Vasopressin via antagonists |
| 03/02/2006 | CA2688912A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2688865A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2619817A1 Thermodynamically stable polymorph of an azabicyclohexane |
| 03/02/2006 | CA2580719A1 Small molecules that replace or agonize p53 function |
| 03/02/2006 | CA2578838A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 03/02/2006 | CA2578560A1 Dihydropteridinones, method for the production thereof, and use thereof as a medicament |
| 03/02/2006 | CA2578407A1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 03/02/2006 | CA2578404A1 Gastric therapies and compositions therefor |
| 03/02/2006 | CA2578370A1 Triazolobenzodiazepines and their use as vasopressin antagonists |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/02/2006 | CA2578175A1 Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2578122A1 Pyrimidine derivatives |
| 03/02/2006 | CA2578117A1 Treatment of posterior capsule opacification |
| 03/02/2006 | CA2578093A1 Composition containing fermentable polysaccharides |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2577982A1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |